FR2293941B1 - - Google Patents

Info

Publication number
FR2293941B1
FR2293941B1 FR7537162A FR7537162A FR2293941B1 FR 2293941 B1 FR2293941 B1 FR 2293941B1 FR 7537162 A FR7537162 A FR 7537162A FR 7537162 A FR7537162 A FR 7537162A FR 2293941 B1 FR2293941 B1 FR 2293941B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7537162A
Other languages
French (fr)
Other versions
FR2293941A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2293941A1 publication Critical patent/FR2293941A1/fr
Application granted granted Critical
Publication of FR2293941B1 publication Critical patent/FR2293941B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7537162A 1974-12-09 1975-12-04 Nouveaux derives des kanamycines a et b et leur preparation Granted FR2293941A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53078774A 1974-12-09 1974-12-09

Publications (2)

Publication Number Publication Date
FR2293941A1 FR2293941A1 (fr) 1976-07-09
FR2293941B1 true FR2293941B1 (da) 1978-11-10

Family

ID=24114972

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7537162A Granted FR2293941A1 (fr) 1974-12-09 1975-12-04 Nouveaux derives des kanamycines a et b et leur preparation

Country Status (17)

Country Link
JP (1) JPS51105036A (da)
BE (1) BE836292A (da)
CA (1) CA1052780A (da)
CH (1) CH621558A5 (da)
CS (1) CS191168B2 (da)
DE (1) DE2555405A1 (da)
DK (1) DK149775B (da)
FR (1) FR2293941A1 (da)
GB (1) GB1535215A (da)
HU (1) HU175575B (da)
IE (1) IE42179B1 (da)
LU (1) LU73957A1 (da)
NL (1) NL7514322A (da)
SE (1) SE435513B (da)
SU (1) SU581873A3 (da)
YU (1) YU306475A (da)
ZA (1) ZA757652B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000473B1 (en) * 1977-06-24 1981-03-11 Scherico Ltd. Process for preparing aminoglycoside derivatives, novel derivatives obtained and pharmaceutical compositions containing such derivatives
EP3150617B1 (en) 2007-11-21 2020-04-08 Cipla USA, Inc. Antibacterial aminoglycoside analogs
WO2010132759A1 (en) 2009-05-15 2010-11-18 Achaogen, Inc. Antibacterial derivatives of dibekacin
WO2010132760A1 (en) 2009-05-15 2010-11-18 Achaogen, Inc. Antibacterial derivatives of tobramycin
WO2010132757A2 (en) 2009-05-15 2010-11-18 Achaogen, Inc. Antibacterial aminoglycoside analogs
WO2010132768A1 (en) 2009-05-15 2010-11-18 Achaogen, Inc. Antibacterial derivatives of sisomicin
WO2010132765A2 (en) 2009-05-15 2010-11-18 Achaogen, Inc. Antibacterial aminoglycoside analogs
EP2616079B1 (en) 2010-09-13 2015-10-14 University of Zürich Treatment of bacterial infectious diseases
US9981896B2 (en) 2016-07-01 2018-05-29 Res Usa, Llc Conversion of methane to dimethyl ether
WO2018004993A1 (en) 2016-07-01 2018-01-04 Res Usa, Llc Reduction of greenhouse gas emission
WO2018004994A1 (en) 2016-07-01 2018-01-04 Res Usa, Llc Fluidized bed membrane reactor

Also Published As

Publication number Publication date
SE7513804L (sv) 1976-06-10
IE42179L (en) 1976-06-09
HU175575B (hu) 1980-09-28
DE2555405A1 (de) 1976-06-10
NL7514322A (nl) 1976-06-11
SU581873A3 (ru) 1977-11-25
ZA757652B (en) 1976-11-24
LU73957A1 (da) 1976-11-11
CA1052780A (en) 1979-04-17
FR2293941A1 (fr) 1976-07-09
DK149775B (da) 1986-09-29
SE435513B (sv) 1984-10-01
JPS51105036A (en) 1976-09-17
GB1535215A (en) 1978-12-13
AU8688275A (en) 1977-06-02
CH621558A5 (en) 1981-02-13
BE836292A (fr) 1976-06-04
DK551075A (da) 1976-06-10
YU306475A (en) 1982-05-31
CS191168B2 (en) 1979-06-29
IE42179B1 (en) 1980-06-18

Similar Documents

Publication Publication Date Title
JPS573679B2 (da)
JPS50109578A (da)
JPS50107508A (da)
FR2264513B3 (da)
AU495920B2 (da)
JPS50124979U (da)
JPS50126243U (da)
BG21358A1 (da)
BG22933A1 (da)
BG19680A1 (da)
BG19621A1 (da)
BE836983A (da)
AU482284A (da)
AU480879A (da)
BG20437A1 (da)
BG20495A1 (da)
BG20910A1 (da)
BG20912A1 (da)
BG20931A1 (da)
BG21119A1 (da)
BG21133A1 (da)
BG21264A1 (da)
BG21284A1 (da)
BG21341A1 (da)
BG20191A1 (da)

Legal Events

Date Code Title Description
ST Notification of lapse